UDG Healthcare Public Limited Co. Notice of Q3 2018 Trading Update - Replacement (7443U)
July 16 2018 - 5:56AM
UK Regulatory
TIDMUDG
RNS Number : 7443U
UDG Healthcare Public Limited Co.
16 July 2018
The following announcement replaces the previously released
RNS:
Headline - Notice of Q3 2018 trading update, released at
10.16am, under RNS number 7376U.
The below now includes the room number and participant pin
required to access the call.
Full amended text appears below.
16 July 2018
UDG Healthcare plc
Notice of Q3 2018 Trading Update
UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading
international healthcare services provider, will issue a trading
update for the third quarter to 30 June 2018 at 7.00am (BST) on
Wednesday 8 August 2018.
The Company will also host a conference call for investors and
analysts at 9:00am (BST) on Wednesday 8 August 2018 to discuss the
statement. The dial-in details are as follows:
International Access +44 (0) 203 936 1888
UK Local Access 0203 936 1888
---------------------
Ireland Local Access 0155 30187
---------------------
USA Local Access 16469680351
---------------------
Room number 985391
---------------------
Participant PIN 8469
---------------------
A playback facility will be available for seven days on 0203 936
1888. The access code for the replay will be 517509
For further information, please contact:
Keith Byrne
Head of Investor Relations, Strategy & Corporate
Communications
UDG Healthcare plc
Tel: +353-1-468-9000
Lisa Kavanagh / Jana Tsiligiannis
Powerscourt
Tel: +44-207-250-1446
Email: udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering advisory, communication, commercial, clinical
and packaging services to the healthcare industry, employing 9,000
people with operations in 25 countries and delivering services in
over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in advisory, communication,
commercial and clinical services for the pharmaceutical and
healthcare industries.
It focuses on supporting healthcare professionals and patients
at all stages of the product life cycle. The division provides
field and contact centre sales teams, healthcare communications,
patient support, audit, advisory, medical information and event
management services to over 300 healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
healthcare industries, operating from state-of-the-art facilities
in the US and Europe.
Aquilant is a leading provider of outsourced sales, marketing,
engineering and distribution services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORLIFSADAIRLIT
(END) Dow Jones Newswires
July 16, 2018 05:56 ET (09:56 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024